Replies to post #113569 on Biotech Values

[y3maxx]

"Cowen’s Eric Schmidt just wrote a “quick take” report estimating that NVS’ 4Q10 end-user Lovenox sales were $200-225M, which is consistent with my run-rate estimate in #msg-59286675. FWIW"

Dew, are you saying NVS reported $170 million while MNTA will report $200 - $225 million fo Q4?

tia

Y3

[jbog]

Dew,

I think we're in the same ballpark with our numbers. We'll have to watch the orals eventually.